全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

phb在生物医学中的应用研究进展

, PP. 85-91

Keywords: 聚β-羟基丁酸酯,微球,多孔薄膜,抗癌药物,缓释

Full-Text   Cite this paper   Add to My Lib

Abstract:

本文综述了新型生物可降解材料聚β-羟基丁酸酯在用作药物缓释载体材料以及其它生物医学材料方面的应用研究进展和发展趋势.

References

[1]  张连来,邓先模.生物发醉法合成热塑性聚脂―聚β-羟基丁酸脂.高分子通报.1993.1:1-8
[2]  howellser.opportunitiesinbiotechnologyforthechemicalindustry.cheat&ind.1982,august;508-511
[3]  thenetherlandsorgancenter.aialegradablepolymericsubstrateloadedwithactivesubstancesforcontrolledreleasethroughamembrane.thenetherlandspat.appl.nl8401925(1985)
[4]  sandowj,seidelhr.microcapsuleofregulatorypeptideswithcontrolledrelease;manufactureandinjectionpreparation.eurpatappl172422(1985);ger.offende3428372(1986)
[5]  saitot,tomitak,juniketal.invivoandinvitrodegradationofpoly(3-hydroxybutyrate)inrat.biorrsnlerrrls.1991,12:309-312
[6]  kubotam,nakanom,junik.mechanismofenhancementofthereleaserateofaclarubicinfrompoly(3-hydroxybutyrateacid)mictaspheresbyfattyacidesters.clrerrrphnrmball.1987,36,333-337
[7]  junik,nakanom,kubotaetal.controlledreleaseofaclarubicinfrompoly(3-hydroxybutyrate)microspheres.ignkanoayume.1985,132(10):735-736
[8]  kellyp.thesustainedreleaseoferythromycinfromsolventcastfilmsofphbvcopolymerscontainingporosgens,drugtargetingdetuery.1992.1:33-43
[9]  korsatko-wabneggb,korsatkow.formulationsofcoatedtabletswithdelayed-releaseeffectusingpoly(d-3-hydroxybutyrate).plurrntnae.1991,46(3),204-206
[10]  nishidak,satom.coatedslow-releasefertdizers,jpnkokaitokkyokohojp0597561(1993)
[11]  humker,seidelhr,vonrw.parenteralsustained-releasepharmaceuticscontainingbiodegradablepeptide(activeagent)andcalciumacetate-glyceroladducts(additive).geroffen.de3642662(1988)
[12]  humker,seidelhr,vonrw.controllal-releaseparenteralimplantsfrompoly(3-hydroxybutyrate).eurpat.applep262583(1988)
[13]  kamatat,numazawar,kamj.microporousmembranesforclinicaluses.jpnkokaitokkyokohojp60137.102(1985)
[14]  dobrovolskayajk,kuzminanl,biberbl.supermolecularstructureofpoly(β-hydroxybutyrate)films.kdimvoloknn.1992,5:18
[15]  doiy,kiuchik.ohorim,phbvporousfilmsformedicaluses.jpnkokaitokkyokohojp04326932(1992)
[16]  rheimerp.polyurethaneorpolyurethane-polyhydroxybutyratecompositemicroporousmembranesaspericardialsubstitutes.colloidpolymsci.1987,265.971-977
[17]  kamatat,odam.membraneswithnarrowporedistrbutions.jpnkokaitokkyokohojp61254203(1986)
[18]  clarottig,aitba,abdellahsetal.modificationofmembranesurfacesbyplasmadepositionofthinfluorocarbonfilmswithoutaffectionbulkproperties.makronmolchem.1991,192(11)1581-1590
[19]  webba,adsettsjr.wounddrmsing.brit.ukpat.appl.gb2166354(1986)
[20]  icipcl.preparationofunwovenmaterialsfrompoly(3-hydroxybutyrate).jpnkokaitokkyokohojp6190667(1986)
[21]  holmesp.sterilizaipoly(3-hydroxybutyrate)powders.brltukpat.appl.gb2160208(1985)
[22]  tormalap,rokkanenr,laihojelal.absorbablereinforcedcompositepolymericboneimplantsandimplantablecomponents.finnpat.fi75493(1988)
[23]  doylec,tanneret,bonfieldw.invitroandinvivoevaluationofpolyhydroxybutyrateandofpolyhydroxybutyratereinforcedwithhydroxyapatite.bionuderinls.1991,12,841-847
[24]  knowelsjc,hastingsgw,ohtahetal.developmentofadegradablecompositefororthopedicuses;invivobiomechanicalandbiologocalevaluationoftwobioactivedegradablecompositesbasedonpolyhydroxybutyratepolymers.biomaterials.1992,13(8):491-496
[25]  hollandsj,yasinm,tighebj.polymersforbiodegradablemedicaldeviees,ⅶ.hydroxybutyrate-hydroxyvaleratecopolymers;degradationofcopolymersandtheirblendswithpolysaccharidesunderinvitrophysiologicalconditions.bbmaterirtls.1990,11:206-215
[26]  dekoninggjm,lemstrapj.crystallizationphenomenainbacterialphb,embrittlementandrejuvenation.polymer.1992.34(19):4089-4094
[27]  kooshaf,mullerrh,davisssetal.thesurfacechemicalstructureofphbmicroparticlesproducedbysolvent-evaporationprocess.jcontrolledrelense.1989,9(2):149-157
[28]  embletonjk,tighebj.polymersforbiodegradablemedicaldevices,n.microencapsulationstudies:effectofpolymercomposition:onphrvmicrocapsulemorphology.j.miicrocapsnlation.1992,9(1):73-87
[29]  embletonjk.tigheaj.polymersforbiodegradablemedicaldevices,x.microencapsulationstudies;controlofphr,phavmicrocapsuleporosityviapcl.j.miicrocapsnlation.1993,10(3);341-352
[30]  abeh,yamamotoy,doiyelal.preparationofpoly(3-hydroxybutyrate)microspherescontaintingfastetofananticancerdruganditsapplicationtodrugdeliverysystems.kobrrnaherunbaeslm.1992,49(1):61-67
[31]  yamamtoy,abeh,ibiyetal.anexperimentalstudyonthereleasingrateofpoly(3-hydroxybutyrate)micraspheres.drugdrlirrrysyst.1992,7(5):367-371
[32]  yamamotoy.abeh,doiye1etal.anexperimentalstudyonthedrugreleaseratefrompoly(3-hydroxybutyrate)micraspheresi.dragdelinerysyst.1993.8(2):131-136
[33]  kawagachit,tsuganea,higashidek.controlofdrugreleasewithacombinationofprodrugandpolymermatrix;antitumeiactivityandreleaseprofilesof3’5’-diacyl-5-fluoro-2’-deoxyuridinefrompoly(3-hydroxybutyrate)micraepheres.jplurrmscr.1992,81(6):508-512
[34]  pricejc.gangraden.phbvmicrosphernscontainingprogesterone,preparation,morphologyandreleaseproperties.j.microenapsulation.1991.8(2):185-202
[35]  korsatkon,korsatkob,laffertyrmetal.astudyontheformulationandthereleaseoftetraceinefrompoly(3-hydroxybutyrate)microspheres.in:aiachejm,hirtzj.ods.proc3rdsurco:tgrbiaplurcmpharmaco.france,1987,1:213-251
[36]  brophymr,ikasypb.invitroandinvivostudiesonbialegradablepolyestermicroparticlescontainingsulfamethizole.int.j.plarnt.1986,29(2-3):223-231
[37]  handjenirm,ribieta.topicalpharmaceuticalsandcosmeticscontainingbialegradablenanoparticlesforskintreatments.eurpat.applep997318(1991)
[38]  traum,trussrw.phbvparticlesforcontrolledreleaseofagrochemicalsandpharmaceutics.eur.pat.applep293172(1988)
[39]  gouldpl,hollandsj,tighebj.polymersforbiodegradablemedicaldevices,iv.hb-hvcopolymersasnon-disintegrationmatrixforcontrollal-releaseoralforms.intjplmrm.1987,38(1-3),231-137
[40]  korsatkon,korsatkob,lettertyrmetnl.thelntluenceofmolecularweightsofpoly(3-hydroxybutyrate)onitsuseasaretardmatrxforsustaineddrugrelease,in,aiachejm,hirtzj.eds.pros3rlrurcoayraiothrrrrnplukmnco.france,1987,1:234-212
[41]  trathniggb,weidmannv,laffertyrmetal.lowmolecularweightpoly(3-hydroxybutyrates)synthesisanduses,angewmakromalchem.1988.161:1-8
[42]  korsatko-wabneggb,korsatkow.compresseddrugformulationscomprisingd(-)-hydroxybutyricacidhomo-andcopolymers.eurpat.applep429832(1991)
[43]  korsatko-wabneggb,korsatkow.compressedsustained-releasedrugformulations.geroffen.de39335736(1991)
[44]  collinsaem,deasypb,maccarthydj.evaluationofacontrolled-releasetabletcontainingtetracycvne-hclbondedtotoothforthetreatmentofperiafontaldiseases.lnljp/rtrm.1989,51(2):103-114
[45]  gangradenk.formulationandinvitroandinvivoevaluationofimplantablemicrospheresandpelletsofphbvcontainingprogesterone.univ.microfilm(univ.georgia,ga),orderno.9206951;dissabstrlae.b,52(9).4678(1992)
[46]  kamatat,odam.preparationofporousmembranesfrompoly(3-hydroxybutyrate).jpnkokaitokkyokohojp60137402(1985)
[47]  lehmannlt.surgicalfilamentcoatingscontainingcalciumstearoyliactylateorphav.uspatent,4711241(1987)
[48]  millernd,williamsdf.tinthebiodagradationofpoly(β-hydroxybutyrate)(pbh)homopolymersandpoly-β-hydroxybutyrate-hydroxyvaleratecopolymers.biomderinls.1987,8,129-137

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133